MICROSYNBIOTIX
MicroSynbiotiX engages in the development of a technology solution that eliminates the excessive use of antibiotics in farmed fish. With MicroSynbiotiX's advances in algal genomics and molecular biology, microalgae can be engineered to express inexpensive therapeutic proteins and vaccines of economic value. By using microalgae as an oral delivery vehicle, MicroSynbiotiX substantially cuts the labor and post-processing production costs, allowing the production of effective vaccines that are much ... more affordable and user-friendly. The technology can eliminate the use of antibiotics, reduce fish mortality rates in aquaculture farms, prevent bacterial and viral diseases from wiping out entire fish stocks, and improve global food security. MicroSynbiotiX was founded on 2016 and is headquartered in Cork City, Ireland.
MICROSYNBIOTIX
Industry:
Aquaculture Biotechnology Farming Therapeutics
Founded:
2016-01-01
Address:
Cork, Cork, Ireland
Country:
Ireland
Website Url:
http://www.microsynbiotix.com
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
1.62 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Google Analytics ReCAPTCHA AJAX Libraries API Google Analytics Classic Vimeo Snowplow Weebly
Similar Organizations
ATAI Life Sciences
ATAI Life Sciences develops innovative mental health treatments that address significant unmet medical needs.
Bright Peak Therapeutics
Bright Peak is a biotech company that develops a portfolio of immunotherapies for the treatment of cancer and autoimmune diseases.
Hookipa Pharma
Hookipa is a clinical stage biotech company developing best-in-class active immunization therapies for infectious diseases and oncology.
NFlection Therapeutics
NFlection focuses on the development of novel therapies to address the needs of patients.
Scout Bio
Scout Bi is a biotechnology company that provides veterinary, animal health, and gene therapy.
Slingshot Biosciences
Slingshot Biosciences develops next-generation synthetic cells for diagnostics and therapeutics.
Current Employees Featured
Founder
Investors List
SOSV
SOSV investment in Convertible Note - MicroSynbiotiX
RebelBio
RebelBio investment in Convertible Note - MicroSynbiotiX
SOSV
SOSV investment in Convertible Note - MicroSynbiotiX
RebelBio
RebelBio investment in Convertible Note - MicroSynbiotiX
Alimentos Ventures
Alimentos Ventures investment in Seed Round - MicroSynbiotiX
SOSV
SOSV investment in Seed Round - MicroSynbiotiX
The Yield Lab Europe
The Yield Lab Europe investment in Seed Round - MicroSynbiotiX
RebelBio
RebelBio investment in Seed Round - MicroSynbiotiX
Enterprise Ireland
Enterprise Ireland investment in Seed Round - MicroSynbiotiX
SOSV
SOSV investment in Convertible Note - MicroSynbiotiX
Official Site Inspections
http://www.microsynbiotix.com
- Host name: pages-custom-8.weebly.com
- IP address: 199.34.228.48
- Location: San Francisco United States
- Latitude: 37.7642
- Longitude: -122.3993
- Metro Code: 807
- Timezone: America/Los_Angeles
- Postal: 94107
More informations about "MicroSynbiotiX"
MicroSynbiotiX - Crunchbase Company Profile & Funding
MicroSynbiotiX engages in the development of a technology solution that eliminates the excessive use of antibiotics in farmed fish. With …See details»
Microsynbiotix Company Profile 2024: Valuation, Investors
Information on acquisition, funding, cap tables, investors, and executives for Microsynbiotix. Use the PitchBook Platform to explore the full profile. Request a free trial Log inSee details»
Microsynbiotix - VentureRadar
MicroSynbiotiX is developing cost-effective oral vaccines to combat these infections and improve global food security. We are developing a novel, patented method of producing oral vaccines …See details»
Sundew acquires MicroSynbiotiX - 2021-11-19 - Crunchbase
MicroSynbiotiX MicroSynbiotiX engages in the development of a technology solution that eliminates the excessive use of antibiotics in farmed fish. Acquiring Organization: Sundew …See details»
MicroSynbiotiX - SOSV
Nov 19, 2021 · MicroSynbiotiX is developing cost-effective oral vaccines to combat infections and improve global food security. We are developing a novel method of producing oral vaccines using transgenic microalgae.See details»
MicroSynbiotiX - Funding, Financials, Valuation & Investors
MicroSynbiotiX engages in the development of a technology solution that eliminates the excessive use of antibiotics in farmed fish.See details»
Microalgae into medicine: Biotech startup targets …
Nov 27, 2017 · MicroSynbiotiX, a biotechnology startup based in Ireland with offices in San Diego, Calif., believes it has a leg up. The company is employing the power of transgenic microalgae to make it cheaper and easier for …See details»
MicroSynbiotiX - Products, Competitors, Financials, Employees ...
MicroSynbiotiX is developing novel oral vaccines for aquaculture. Their vaccines will help to eliminate the unnecessary use of antibiotics, and to combat devastating viral outbreaks …See details»
Bioventure Sundew Acquires MicroSynbiotiX And Completes €
Nov 18, 2021 · Sundew, a Dutch-Danish biotech startup focused on combating aquatic pests, diseases and invasive species, announced today the acquisition of MicroSynbiotiX in an all …See details»
MicroSynbiotiX - EU-Startups
MicroSynbiotiX is a Biotechnology startup based in Cork, Ireland. The company's mission is to create a potentially revolutionary algal platform technology. With the advance in algal …See details»
Startup Stories: MicroSynbiotiX research MicroAlgae to …
Jun 3, 2017 · MicroSynbiotiX, an early-stage biotech company based in Ireland, is developing oral vaccines to prevent infectious diseases in farmed fish. We spoke with CEO and co-founder, Simon Porphy, about his transgenic microalgae …See details»
Meet the Start-up that Secured a Million Euros in Seed ... - HuffPost
Sep 4, 2017 · What we do at MicroSynbiotiX- Microalgae oral vaccines/functional feed additives. MSX’s funding round is led by Alimentos Ventures , together with SOSV, a US-based venture …See details»
Sundew acquires MicroSynbiotiX bringing along algal RNA …
Nov 24, 2021 · MSX’s algal RNA interference (RNAi)-based production and delivery technologies provide Sundew with additional capabilities and product lines in its mission to provide effective, …See details»
MicroSynbiotiX - Contacts, Employees, Board Members, Advisors …
MicroSynbiotiX has 4 current employee profiles, including CEO and Co-Founder Antonio Lamb. MicroSynbiotiX engages in the development of a technology solution that eliminates the …See details»
Cork-based MicroSynbiotix secures €1m to tackle fish stock …
MicroSynbiotiX, a Cork-based biotech start-up that is developing oral vaccines to help combat infections in fish stocks, has secured €1 million in seed funding from investors which include...See details»
Vaccinating fish through feed: Irish firm shows feasibility of ...
Jun 12, 2018 · Irish biotech company, MicroSynbiotiX Ltd, says it is making significant progress around proof of concept of its edible vaccine system, showing that it can use microalgae as an …See details»
MicroSynbiotix uses synbio to help fish farming
Nov 10, 2016 · Microsynbiotix offers transgenic algae that contain vaccines – fish eat the algae in the aquafarm and get immunized against bacterial or viral infections. Currently, most of the …See details»
Sundew acquires MicroSynbiotiX and completes €1.4 M financing
Nov 18, 2021 · Sundew acquires MicroSynbiotiX and completes €1.4 M financing. 18 Nov. Written By Rob Kester. Addition of algal RNA platform & pipeline accelerates Sundew’s …See details»
Microsynbiotix | Cork - Facebook
Microsynbiotix, Cork. 977 likes. We provide cost-effective oral delivery of vaccines for fish farming. We are developing a patent-pending platform technology using microalgae.See details»
MicroSynbiotiX - Responsible Seafood Advocate
MicroSynbiotiX is employing the power of transgenic microalgae to make it cheaper and easier for aquaculture producers to administer vaccines to fish.See details»